Codex DNA Inc Aktie News

Telesis Bio, Inc. (NASDAQ:DNAY ) Q3 2022 Earnings Conference Call November 8, 2022 4:30 PM ET Company Participants Todd Nelson - CEO Brent Hunter - VP, Finance Conference Call Participants Brandon Couillard - Jefferies Operator Welcome to the Q3 2022 Telesis Bio Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: DNAY), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its third quarter 2022 financial results on Tuesday, November 8, 2022, after the market closes. In conjunction with the release, management will host a conference call the same day at 1:30 p.m. Pacific Time / 4:30 p.m. Ea...

Novel name reflects expansion of capabilities and solutions Novel name reflects expansion of capabilities and solutions

Codex DNA, Inc. (NASDAQ:DNAY ) Q2 2022 Earnings Conference Call August 9, 2022 4:30 PM ET Company Participants Todd Nelson - Chief Executive Officer Brent Hunter - VP of Finance Conference Call Participants Brandon Couillard - Jefferies Operator Good day, and thank you for standing by. Welcome to the Q2 2022 Codex DNA, Incorporated Earnings Conference Call.

SAN DIEGO, June 02, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that Todd R. Nelson, PhD, the company's chief executive officer, will present at the 2022 Jefferies Healthcare Conference on Friday, June 10th at 9:00 am Eastern time / 6:00 am Pacific Time.

BioXp™ system and RapidAMP™ cell-free DNA kit rapidly accelerate antibody discovery pipelines by addressing critical bottlenecks associated with lead candidate gene synthesis, cloning, and scale-up

Codex DNA, Inc. (NASDAQ:DNAY ) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Richard Lepke - Director, Investor Relations Todd Nelson - Chief Executive Officer Jennifer McNealey - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Paul Knight - KeyBanc Steven Mah - Cowen Operator Good afternoon, ladies and gentlemen and welcome to ...

SAN DIEGO, May 03, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced that it will release its first quarter 2022 financial results on Tuesday, May 10, 2022, after the market closes. In conjunction with the release, management will host a conference call on Tuesday, May 10, 2022, at 1:30 p.m. Pacific Time / 4:30 p....